Wave Life Sciences Ltd. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | 11/14/2024 | 18.20 M | $149.26 M | 0.00% | 13.73% |
| MAVERICK CAPITAL LTD | 11/14/2024 | 10.05 M | $82.39 M | 31.01% | 7.58% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 11/14/2024 | 9.70 M | $79.57 M | 81.11% | 7.32% |
| BLACKROCK FUNDING, INC. /DE | 11/13/2024 | 7.30 M | $59.85 M | 100.00% | 5.51% |
| M28 CAPITAL MANAGEMENT LP | 11/12/2024 | 6.16 M | $50.55 M | 0.00% | 4.65% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 11/14/2024 | 5.86 M | $48.04 M | 545.18% | 4.42% |
| SIREN, L.L.C. | 11/13/2024 | 5.72 M | $46.91 B | 100.00% | 4.32% |
| KYNAM CAPITAL MANAGEMENT, LP | 11/14/2024 | 4.90 M | $40.18 M | 23.24% | 3.70% |
| 683 CAPITAL MANAGEMENT, LLC | 11/14/2024 | 4.20 M | $34.44 M | -21.13% | 3.17% |
| BELLEVUE GROUP AG | 11/14/2024 | 4.09 M | $33.57 M | 0.00% | 3.09% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 11/14/2024 | 3.13 M | $25.64 M | 117.24% | 2.36% |
| VANGUARD GROUP INC | 11/13/2024 | 2.89 M | $23.68 M | 19.43% | 2.18% |
| EMERALD ADVISERS, LLC | 10/29/2024 | 2.88 M | $23.63 M | 15.57% | 2.17% |
| PRIMECAP MANAGEMENT CO/CA/ | 11/08/2024 | 2.58 M | $21.16 M | -3.13% | 1.95% |
| STATE STREET CORP | 11/14/2024 | 2.32 M | $19.03 M | 2.55% | 1.75% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2024 | 2.27 M | $18.62 M | 14.27% | 1.71% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 10/29/2024 | 2.12 M | $17.41 M | 16.61% | 1.60% |
| ARTISAN PARTNERS LIMITED PARTNERSHIP | 11/12/2024 | 1.96 M | $16.08 M | 100.00% | 1.48% |
| FMR LLC | 11/13/2024 | 1.54 M | $12.63 M | 174.50% | 1.16% |
| AFFINITY ASSET ADVISORS, LLC | 11/13/2024 | 1.40 M | $11.48 M | 273.33% | 1.06% |
| CITADEL ADVISORS LLC | 11/14/2024 | 937,586 | $7.69 M | 3,693.44% | 0.71% |
| RTW INVESTMENTS, LP | 11/14/2024 | 900,000 | $7.38 M | 100.00% | 0.68% |
| MILLENNIUM MANAGEMENT LLC | 11/14/2024 | 851,665 | $6.98 M | -48.83% | 0.64% |
| MAVEN SECURITIES LTD | 11/14/2024 | 850,000 | $6.97 M | 100.00% | 0.64% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/12/2024 | 844,617 | $6.93 M | 209.08% | 0.64% |
| MORGAN STANLEY | 11/14/2024 | 644,335 | $5.28 M | -23.02% | 0.49% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 11/14/2024 | 627,552 | $5.15 M | 26.66% | 0.47% |
| BIOIMPACT CAPITAL LLC | 11/13/2024 | 624,471 | $5.12 M | 100.00% | 0.47% |
| WALLEYE CAPITAL LLC | 11/14/2024 | 602,441 | $4.94 M | 100.00% | 0.45% |
| IKARIAN CAPITAL, LLC | 11/14/2024 | 544,265 | $4.46 M | -5.36% | 0.41% |
| POLAR ASSET MANAGEMENT PARTNERS INC. | 11/14/2024 | 486,023 | $3.99 M | 100.00% | 0.37% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 11/08/2024 | 461,667 | $3.79 M | -14.08% | 0.35% |
| WOODLINE PARTNERS LP | 11/14/2024 | 451,813 | $3.70 M | 100.00% | 0.34% |
| NEWTYN MANAGEMENT, LLC | 11/14/2024 | 425,000 | $3.49 M | -10.53% | 0.32% |
| D. E. SHAW & CO., INC. | 11/14/2024 | 418,461 | $3.43 M | 285.44% | 0.32% |
| NUVEEN ASSET MANAGEMENT, LLC | 11/14/2024 | 416,280 | $3.41 M | 27.35% | 0.31% |
| JPMORGAN CHASE & CO | 12/26/2024 | 375,667 | $3.08 M | -4.18% | 0.28% |
| GOLDMAN SACHS GROUP INC | 11/14/2024 | 374,363 | $3.07 M | 59.35% | 0.28% |
| CINCTIVE CAPITAL MANAGEMENT LP | 11/14/2024 | 356,308 | $2.92 M | 255.73% | 0.27% |
| BAKER BROS. ADVISORS LP | 11/14/2024 | 344,063 | $2.82 M | 100.00% | 0.26% |
| CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | 11/08/2024 | 325,009 | $2.67 M | -4.34% | 0.25% |
| WELLINGTON MANAGEMENT GROUP LLP | 11/14/2024 | 315,502 | $2.59 M | -26.34% | 0.24% |
| MOODY ALDRICH PARTNERS LLC | 10/22/2024 | 303,062 | $2.49 M | 68.97% | 0.23% |
| STEMPOINT CAPITAL LP | 11/13/2024 | 300,000 | $2.46 M | 100.00% | 0.23% |
| TREXQUANT INVESTMENT LP | 11/12/2024 | 288,814 | $2.37 M | 2.76% | 0.22% |
| BANK OF AMERICA CORP /DE/ | 11/14/2024 | 275,076 | $2.26 M | 266.41% | 0.21% |
| MONASHEE INVESTMENT MANAGEMENT LLC | 11/12/2024 | 260,000 | $2.13 M | 100.00% | 0.20% |
| TD ASSET MANAGEMENT INC | 11/01/2024 | 251,806 | $2.09 M | 36.89% | 0.19% |
| BANK OF NEW YORK MELLON CORP | 11/12/2024 | 201,830 | $1.66 M | -10.46% | 0.15% |
| BOOTHBAY FUND MANAGEMENT, LLC | 11/14/2024 | 174,112 | $1.43 M | 3.91% | 0.13% |
Wave Life Sciences Ltd.institutional Ownership - FAQ's
During the previous two years, 193 institutional investors and hedge funds held shares of Wave Life Sciences Ltd.. The most heavily invested institutionals were:
RA CAPITAL MANAGEMENT, L.P.: 18.2 M
MAVERICK CAPITAL LTD: 10.05 M
ADAGE CAPITAL PARTNERS GP, L.L.C.: 9.7 M
BlackRock Funding, Inc. /DE: 7.3 M
M28 Capital Management LP: 6.16 M
DRIEHAUS CAPITAL MANAGEMENT LLC: 5.86 M
89.61% of Wave Life Sciences Ltd. stock is owned by institutional investors.
Institutional investors have bought a total of 220.70 M shares in the last 24 months. This purchase volume represents approximately $2.86 B in transactions.